tradingkey.logo

tradingkey.logo
怜玢


Boston Scientific Corp

BSX
りォッチリストに远加
53.370USD
-0.560-1.04%
終倀 05/11, 16:00ET15分遅れの株䟡
79.32B時䟡総額
22.20盎近12ヶ月PER


詳现情報 Boston Scientific Corp 䌁業名

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

Boston Scientific Corpの䌁業情報


䌁業コヌドBSX
䌚瀟名Boston Scientific Corp
䞊堎日May 19, 1992
最高経営責任者「CEO」Mahoney (Michael F)
埓業員数53000
蚌刞皮類Ordinary Share
決算期末May 19
本瀟所圚地300 Boston Scientific Way
郜垂MARLBOROUGH
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United States of America
郵䟿番号01752-1234
電話番号15086834000
りェブサむトhttps://www.bostonscientific.com/en-US/Home.html
䌁業コヌドBSX
䞊堎日May 19, 1992
最高経営責任者「CEO」Mahoney (Michael F)

Boston Scientific Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
41.58K
--
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
24.13K
--
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
5.63K
--
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.08K
--
Mr. Joseph M. Fitzgerald
Mr. Joseph M. Fitzgerald
Executive Vice President, Group President - Cardiology
Executive Vice President, Group President - Cardiology
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
41.58K
--
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
24.13K
--

収益内蚳

通貚: USD曎新時刻: Thu, Apr 2
通貚: USD曎新時刻: Thu, Apr 2
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
事業別USD
䌚瀟名
収益
比率
Interventional Cardiology Therapies
4.64B
23.11%
Electrophysiology
3.33B
16.56%
Endoscopy
2.92B
14.53%
Urology
2.71B
13.50%
Cardiac Rhythm Management
2.33B
11.62%
他の
4.15B
20.69%
地域別USD
䌚瀟名
収益
比率
United States
12.86B
64.08%
EMEA (Europe, Middle East and Africa)
3.45B
17.19%
Asia Pacific
3.08B
15.34%
Latin America and Canada
678.00M
3.38%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Interventional Cardiology Therapies
4.64B
23.11%
Electrophysiology
3.33B
16.56%
Endoscopy
2.92B
14.53%
Urology
2.71B
13.50%
Cardiac Rhythm Management
2.33B
11.62%
他の
4.15B
20.69%

株䞻

曎新時刻: Sun, May 10
曎新時刻: Sun, May 10
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Vanguard Capital Management, LLC
6.49%
Fidelity Management & Research Company LLC
5.85%
BlackRock Institutional Trust Company, N.A.
5.40%
State Street Investment Management (US)
4.43%
Geode Capital Management, L.L.C.
2.18%
他の
75.65%
株䞻統蚈
株䞻統蚈
比率
Vanguard Capital Management, LLC
6.49%
Fidelity Management & Research Company LLC
5.85%
BlackRock Institutional Trust Company, N.A.
5.40%
State Street Investment Management (US)
4.43%
Geode Capital Management, L.L.C.
2.18%
他の
75.65%
皮類
株䞻統蚈
比率
Investment Advisor
51.84%
Investment Advisor/Hedge Fund
26.29%
Hedge Fund
6.11%
Pension Fund
3.03%
Research Firm
2.82%
Bank and Trust
2.02%
Sovereign Wealth Fund
1.83%
Private Equity
0.23%
Individual Investor
0.19%
他の
5.65%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q1
3113
1.40B
94.35%
-15.51M
2025Q4
2858
1.40B
94.34%
-402.85K
2025Q3
2905
1.40B
94.56%
+9.92M
2025Q2
2818
1.39B
94.08%
+7.87M
2025Q1
2724
1.38B
93.98%
-8.23M
2024Q4
2559
1.38B
93.68%
+12.79M
2024Q3
2401
1.36B
94.13%
-3.01M
2024Q2
2325
1.37B
94.20%
+2.64M
2024Q1
2212
1.37B
95.15%
-32.63M
2023Q4
2153
1.38B
96.34%
-8.17M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Fidelity Management & Research Company LLC
86.99M
5.85%
-3.63M
-4.01%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
80.23M
5.4%
+634.35K
+0.80%
Dec 31, 2025
State Street Investment Management (US)
65.85M
4.43%
+920.50K
+1.42%
Dec 31, 2025
Geode Capital Management, L.L.C.
32.38M
2.18%
-306.76K
-0.94%
Dec 31, 2025
PRIMECAP Management Company
31.10M
2.09%
-2.01M
-6.06%
Dec 31, 2025
Capital World Investors
27.15M
1.83%
+502.63K
+1.89%
Dec 31, 2025
Norges Bank Investment Management (NBIM)
23.07M
1.55%
+3.61M
+18.55%
Dec 31, 2025
The Bollard Group, LLC
19.00M
1.28%
-733.10K
-3.72%
Dec 31, 2025
詳现を芋る

関連ETF


曎新時刻: Mon, Dec 1
曎新時刻: Mon, Dec 1
銘柄名
比率
iShares U.S. Medical Devices ETF
12.15%
Goldman Sachs Future Health Care Equity ETF
8.33%
Invesco Dorsey Wright Healthcare Momentum ETF
3.87%
Tema Heart & Health ETF
3.66%
First Trust Bloomberg R&D Leaders ETF
3.14%
Parnassus Core Select ETF
3.1%
WisdomTree US AI Enhanced Value Fund
3.1%
Health Care Select Sector SPDR Fund
3.06%
Global X Aging Population ETF
2.99%
Proshares Ultra Health Care
2.95%
詳现を芋る
iShares U.S. Medical Devices ETF
比率12.15%
Goldman Sachs Future Health Care Equity ETF
比率8.33%
Invesco Dorsey Wright Healthcare Momentum ETF
比率3.87%
Tema Heart & Health ETF
比率3.66%
First Trust Bloomberg R&D Leaders ETF
比率3.14%
Parnassus Core Select ETF
比率3.1%
WisdomTree US AI Enhanced Value Fund
比率3.1%
Health Care Select Sector SPDR Fund
比率3.06%
Global X Aging Population ETF
比率2.99%
Proshares Ultra Health Care
比率2.95%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™